Adding trabectedin to treatment with doxorubicin improved progression-free and overall survival in patients with advanced leiomyosarcoma.

HealthDay News — For patients with breast cancer, moderate hypofractionation (MHF) shows an improved safety profile, cosmesis, and quality of life compared with conventional fractionation (CF), with ...

Investigators in Japan evaluated 1 week of oral naldemedine for treatment of opioid-induced constipation in cancer patients receiving palliative care in a real-world setting.

The hormone sensitivity of breast tissue makes it even more susceptible to damage from ionizing radiation from imaging ...

The effectiveness of the ONCORAL program in identifying drug-related problems in patients receiving oral anticancer therapy was determined in a prospective cohort study.

Belzutifan outperformed everolimus in patients with previously treated, advanced clear-cell renal cell carcinoma in the phase 3 LITESPARK-005 trial.

Bintrafusp alfa has demonstrated activity in a phase 2 trial of patients with recurrent or metastatic cervical cancer.

Cancer rates are increasing in US Millennials and Generation X, according to research published in The Lancet Public Health. 1 Researchers found increases in rates of 17 cancers, including 8 cancers ...

Study compared telehealth with in-person meeting as a modality for effective delivery of early palliative care.

In a retrospective study, investigators compared the risk of progression to end-stage kidney disease (ESKD) following partial nephrectomy and radical nephrectomy among patients with preoperative stage ...

A retrospective study explored the impact of preexisting cardiovascular disease on adverse events in patients with hematologic malignancies receiving BTK inhibitors.

Data suggest that neoadjuvant immune checkpoint inhibitor (ICI) therapy improves outcomes in patients with early-stage triple-negative breast cancer, but adjuvant ICI therapy does not.